Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Cholinergic drugs in pharmacotherapy of Alzheimer's disease.

Camps P, Muñoz-Torrero D.

Mini Rev Med Chem. 2002 Feb;2(1):11-25. Review.

PMID:
12369954
2.

Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer's disease.

Sadashiva CT, Narendra Sharath Chandra JN, Ponnappa KC, Veerabasappa Gowda T, Rangappa KS.

Bioorg Med Chem Lett. 2006 Aug 1;16(15):3932-6. Epub 2006 Jun 2.

PMID:
16735118
3.

Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.

Martinez A, Castro A.

Expert Opin Investig Drugs. 2006 Jan;15(1):1-12. Review.

PMID:
16370929
4.

Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?

Benzi G, Moretti A.

Eur J Pharmacol. 1998 Apr 3;346(1):1-13. Review.

PMID:
9617746
5.

Recent advances in the treatment of Alzheimer's.

Richter RW, Farlow MR.

J Okla State Med Assoc. 1998 Nov;91(8):431-7. Review. No abstract available. Erratum in: J Okla State Med Assoc 1998 Dec;91(9):508. Farlow MJ [corrected to Farlow MR].

PMID:
9828525
6.

Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs.

Grundman M, Corey-Bloom J, Thal LJ.

J Neural Transm Suppl. 1998;53:255-75. Review.

PMID:
9700663
7.

Cholinergic strategies in the treatment of Alzheimer's disease.

Davidson M, Stern RG, Bierer LM, Horvath TB, Zemishlani Z, Markofsky R, Mohs RC.

Acta Psychiatr Scand Suppl. 1991;366:47-51. Review.

PMID:
1897375
8.

Future therapeutic approaches to Alzheimer's disease.

Davis KL.

J Clin Psychiatry. 1998;59 Suppl 11:14-6. Review.

9.

Muscarinic M(1) agonists in the treatment of Alzheimer's disease.

Korczyn AD.

Expert Opin Investig Drugs. 2000 Oct;9(10):2259-67. Review.

PMID:
11060805
10.

[From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease].

Franke AG, Lieb K, Fellgiebel A.

Fortschr Neurol Psychiatr. 2009 Jun;77(6):326-33. doi: 10.1055/s-0028-1109378. Epub 2009 Jun 5. Review. German.

PMID:
19504422
11.

Cholinergic therapies for Alzheimer's disease: progress and prospects.

Palmer AM.

Curr Opin Investig Drugs. 2003 Jul;4(7):820-5. Review.

PMID:
14619403
12.
13.
14.

Reappraising neurotransmitter-based strategies.

Möller HJ.

Eur Neuropsychopharmacol. 1999 Apr;9 Suppl 2:S53-9. Review.

PMID:
10332935
15.

New anti-Alzheimer drugs from biodiversity: the role of the natural acetylcholinesterase inhibitors.

Viegas C Jr, Bolzani Vda S, Barreiro EJ, Fraga CA.

Mini Rev Med Chem. 2005 Oct;5(10):915-26. Review.

PMID:
16250834
16.

Cholinergic therapies for Alzheimer's disease. Palliative or disease altering?

Davis RE, Doyle PD, Carroll RT, Emmerling MR, Jaen J.

Arzneimittelforschung. 1995 Mar;45(3A):425-31. Review.

PMID:
7763338
17.

Alzheimer's disease: cognitive and behavioral pharmacotherapy.

Cummings JL, Mendez MF.

Conn Med. 1997 Sep;61(9):543-52. Review.

PMID:
9334509
18.

New concepts in the drug therapy of Alzheimer's disease.

Hake AM, Farlow MR.

Expert Opin Pharmacother. 2001 Dec;2(12):1975-83. Review.

PMID:
11825329
19.
20.

Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.

Musiał A, Bajda M, Malawska B.

Curr Med Chem. 2007;14(25):2654-79. Review.

PMID:
17979717

Supplemental Content

Support Center